Search results
Strengthening CAR-T Therapy to Work Against Solid Tumors
Newswise· 7 days agoThe promising findings, reported today in Science Advances, involve CAR-T cell therapy, which...
Key role found for gut epithelial cells in the defense against deadly diarrheal infections
Medical Xpress· 7 days agoA study published in the journal Nature, led by Carlene Zindl, Ph.D., and C. Garrett Wilson in the research group of Casey Weaver, M.D., at the University of Alabama at Birmingham, brings new ...
INOVIO Reports First Quarter 2024 Financial Results and Recent Business Highlights
WRBL Columbus· 7 hours agoINOVIO (NASDAQ:INO), a biotechnology company focused on developing and commercializing DNA medicines to help treat and protect people from HPV-related diseases, cancer, and infectious diseases ...
Acepodia reports preliminary results from ACE1831 Phase I trial
Clinical Trials Arena via Yahoo Finance· 5 days agoClinical-stage biotechnology company Acepodia has reported preliminary results from the Phase I...
AML/T cell interactomics uncover correlates of patient outcomes and the key role of ICAM1 in T cell...
Nature· 5 days agoSingle-cell RNA-seq of primary AML samples and CD4+ T cells before and after their interaction uncovered transcriptional programs that correlate with AML sensitivity or resistance to CD4+ < ...
AI predicts tumor-killing cells with high accuracy
Newswise· 7 days agoMAY 7, 2024, NEW YORK – Using artificial intelligence, Ludwig Cancer Research scientists have developed a powerful predictive model for identifying the...
Yale Cancer Center Earns International Reaccreditation for Expertise in CAR T-cell Therapy and Stem...
Newswise· 7 days agoSCH is the only cancer hospital in the state offering these lifesaving therapies, including chimeric antigen receptor (CAR) T-cell therapy.
Breakthrough therapies are saving lives, but can we afford them?
Medical Xpress· 11 hours agoLast month, Stanford became the first hospital in the nation to use a new $515,000 cell therapy to...
Researchers discover benefits of adding immune-boosting agent to personalized cancer vaccine
Medical Xpress· 4 days agoThe study, published in Nature Communications, found that pairing a personalized dendritic cell...
Fate Therapeutics Inc (FATE) Q1 2024 Earnings: Mixed Financial P
Guru Focus· 3 days agoThe clinical-stage biopharmaceutical company, known for its innovative programmed cellular immunotherapies for cancer and autoimmune disorders, reported a mix of financial challenges and significant ...